Evidence map›Paper›PMID 41729892›Full record

ArticlePloS one2026

The economic burden of loiasis: A comprehensive cost-of-illness analysis of regionally representative, individual-level data from rural Gabon.

Cédric Isaac Mbavu, Kerstin Perlik, Tom Stargardt, Selidji Todagbe Agnandji, Olouyomi Scherif Adegnika, Rella Zoleko-Manego, Michael Ramharter, Jan Priebe

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cédric Isaac MbavuResearch Group Health Economics, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.
Kerstin PerlikResearch Group Health Economics, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.
Tom StargardtHamburg Center for Health Economics (HCHE), University of Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0003-3954-0955
Selidji Todagbe AgnandjiCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Olouyomi Scherif AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Rella Zoleko-ManegoClinical Research Department, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.ORCID https://orcid.org/0000-0001-7425-2794
Michael RamharterClinical Research Department, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.ORCID https://orcid.org/0000-0002-9259-1885
Jan PriebeResearch Group Health Economics, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Germany.ORCID https://orcid.org/0000-0002-6933-1807

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Loiasis is a vector-borne filarial infection endemic to parts of sub-Saharan Africa. It disproportionally affects economically disadvantaged communities in rural, forested regions. To better understand the economic burden of loiasis, we conducted a comprehensive cost-of-illness study in an endemic region of Gabon, with the aim of quantifying the financial costs incurred by individuals infected with the disease from a societal perspective. We conducted a cross-sectional survey in 2023 in rural Gabon. Study participants took part in diagnostic testing for loiasis and were interviewed based on a standardized questionnaire covering a wide range of medical and non-medical costs. Participants reporting eye worm migration or harboring loiasis microfilariae were defined as loiasis positive. Various cost estimates were derived by creating a synthetic control group by means of entropy-balancing and then applying generalized linear models (GLM) for the study region. We show that the average annual costs directly attributable to loiasis amount to 39.94 USD per individual per year. Average cost estimates are primarily driven by indirect costs and direct non-medical costs. We further show that in the rarer cases that individuals seek treatment at formal or informal healthcare providers for loiasis-specific symptoms, costs from the patient's perspective can be excessively high and amount to about 43 percent of the average monthly per capita income in the study region.

Indexed as

Cost of IllnessLoiasisAdolescentAdultAnimalsChildCross-Sectional StudiesFemaleGabonHealth Care CostsHumansMaleMiddle AgedRural PopulationYoung Adult

Identifiers

PMID41729892
PMCPMC12928485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.